Sign in

CIK 0001515673

  • Large accelerated filer

Ultragenyx Pharmaceutical Inc.

Sign in to watch
Ticker
RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272546083
Phone
+1 415-483-8800
Business address
60 LEVERONI COURT, NOVATO, CA, 94949
  1. 4 Grant or award Director acquired 3,300 shares (grant or award)
  2. 4 Grant or award Director acquired 3,300 shares (grant or award)
  3. 4 Grant or award Director acquired 3,300 shares (grant or award)
  4. 4 Grant or award Director acquired 3,300 shares (grant or award)
  5. 4 Grant or award Director acquired 3,300 shares (grant or award)
  6. 4 Grant or award Director acquired 3,300 shares (grant or award)
  7. 4 Open-market sale EVP & Chief Commercial Officer sold 295 shares at $54.78 ($16,160)
  8. 4 Grant or award Director acquired 5,120 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale SVP, Chief Accounting Officer sold 132 shares at $84.55 ($11,161)
  11. 4 Open-market sale CBO & EVP sold 10,281 shares at $67.01 ($688,930)
  12. 4 Open-market sale EVP and Chief Legal Officer sold 5,140 shares at $62.95 ($323,563)
  13. 4 Exercise or conversion Director acquired 7,500 shares (option exercise)
  14. 4 Open-market sale CFO & Executive Vice President sold 954 shares at an average $65.71 ($62,686)
  15. 4 Open-market sale EVP & Chief Commercial Officer sold 2,713 shares at $66.62 ($180,740)
  16. 4 Open-market sale Pinion John Richard sold 4,498 shares at $66.62 ($299,657)
  17. 4 Open-market sale SVP, Chief Accounting Officer sold 843 shares at $66.62 ($56,161)
  18. 4 Open-market sale Huang Dennis Karl sold 3,234 shares at $66.62 ($215,449)
  19. 4 Open-market sale EVP and Chief Legal Officer sold 2,886 shares at $66.62 ($192,265)
  20. 4 Open-market sale CBO & EVP sold 2,374 shares at $66.62 ($158,156)

Page 8 of 32 · 627 filings